SCNI
Scinai Immunotherapeutics
SCNI
SCNI
17 hedge funds and large institutions have $20.8M invested in Scinai Immunotherapeutics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.74M | |
| 2 | +$776K | |
| 3 | +$645K | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$335K |
| 5 |
MA
Mutual Advisors
Omaha,
Nebraska
|
+$280K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$260K | |
| 3 | -$238K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$79.2K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$50.9K |